A boy with a severe form of aromatic L-amino acid decarboxylase (AADC) deficiency was able to walk independently — and later run — after receiving the gene therapy Kebilidi (eladocagene exuparvovec), according to a new case report. The child, now 5, showed rapid and sustained improvements in movement…